Showing results (101-110 of 217) with videos related to
Sort By:
Pageof 22
Cancer Research|November 18, 2008
Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecanTakako Eguchi Nakajima, Kazuyoshi Yanagihara, Misato Takigahira, et al.British Journal of Cancer|March 23, 2016
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodiesNaoki Takahashi, Satoru Iwasa, Hirokazu Taniguchi, et al.Cancer Chemotherapy and Pharmacology|October 5, 2018
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patientsTetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, et al.International Journal of Clinical Oncology|October 27, 2009
Current therapeutic strategies for anal squamous cell carcinoma in JapanAtsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.Anticancer Research|June 30, 2016
Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal CancerToshifumi Yamaguchi, Satoru Iwasa, Kengo Nagashima, et al.Japanese Journal of Clinical Oncology|November 6, 2020
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702AKiyo Tanaka, Gakuto Ogawa, Junki Mizusawa, et al.BMC Research Notes|April 30, 2014
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.Japanese Journal of Clinical Oncology|November 9, 2012
A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruptionHironobu Hashimoto, Satoru Iwasa, Takako Yanai, et al.Japanese Journal of Clinical Oncology|July 17, 2008
A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancerJunichi Matsubara, Yasuhiro Shimada, Atsuo Takashima, et al.Journal of Geriatric Oncology|January 30, 2026
Primary endpoints in randomized controlled trials for older adults with cancer: A scoping reviewTomonori Mizutani, Funato Sato, Kohei Uemura, et al.Pageof 22